• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: "Efficacy of single‑session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study".

作者信息

Xu Shuhang

机构信息

Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.

出版信息

Eur Radiol. 2025 Apr;35(4):2351-2352. doi: 10.1007/s00330-024-11044-4. Epub 2024 Aug 29.

DOI:10.1007/s00330-024-11044-4
PMID:39207466
Abstract
摘要

相似文献

1
Letter to the Editor: "Efficacy of single‑session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study".致编辑的信：“单疗程射频消融术（RFA）治疗持续性/复发性格雷夫斯病致甲状腺功能正常的疗效，一项初步研究”
Eur Radiol. 2025 Apr;35(4):2351-2352. doi: 10.1007/s00330-024-11044-4. Epub 2024 Aug 29.
2
Correction: Letter to the Editor: "Efficacy of single‑session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study".
Eur Radiol. 2025 Apr;35(4):2359. doi: 10.1007/s00330-024-11073-z.
3
Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.单次射频消融术（RFA）治疗持续性/复发性格雷夫斯病致甲状腺功能正常的疗效：一项初步研究。
Eur Radiol. 2023 Sep;33(9):6534-6544. doi: 10.1007/s00330-023-09620-1. Epub 2023 Apr 10.
4
The Two-Year Results of Using Radiofrequency Ablation as a Novel Treatment for Persistent or Relapsed Graves' Disease: A Prospective Study.射频消融治疗持续性或复发性格雷夫斯病的两年结果：一项前瞻性研究。
Thyroid. 2024 Aug;34(8):1017-1026. doi: 10.1089/thy.2024.0177. Epub 2024 Jul 3.
5
[T-lymphocytes phenotypic composition of peripheral blood in patients with Graves' disease undergoing conservative therapy with thiamazole].[接受甲巯咪唑保守治疗的格雷夫斯病患者外周血T淋巴细胞表型组成]
Probl Endokrinol (Mosk). 2021 Nov 9;67(6):39-49. doi: 10.14341/probl12812.
6
Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.放射性碘治疗格雷夫斯病后甲状腺功能正常持续时间的预测因素：一项初步研究。
Endocr Pract. 2023 Feb;29(2):89-96. doi: 10.1016/j.eprac.2022.11.005. Epub 2022 Nov 14.
7
Use of Adjunctive Therapy to Achieve Preoperative Euthyroidism in Graves' Disease: A Case Report.辅助治疗在格雷夫斯病术前甲状腺功能正常中的应用：一例报告。
Am J Case Rep. 2020 Aug 6;21:e923342. doi: 10.12659/AJCR.923342.
8
Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves' disease.单次高强度聚焦超声（HIFU）治疗持续性或复发性格雷夫斯病的两年结果。
Eur Radiol. 2019 Dec;29(12):6690-6698. doi: 10.1007/s00330-019-06303-8. Epub 2019 Jun 17.
9
Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.抗甲状腺药物治疗 Graves 甲亢：“阻断与替代”和“滴定”方案治疗中甲状腺功能正常和 Graves 眼病的频率差异。
J Endocrinol Invest. 2021 Feb;44(2):371-378. doi: 10.1007/s40618-020-01320-7. Epub 2020 Jun 10.
10
The efficacy of thyroidectomy for Graves' disease: A meta-analysis.甲状腺切除术治疗Graves病的疗效：一项荟萃分析。
J Surg Res. 2000 May 15;90(2):161-5. doi: 10.1006/jsre.2000.5875.

本文引用的文献

1
Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.单次射频消融术（RFA）治疗持续性/复发性格雷夫斯病致甲状腺功能正常的疗效：一项初步研究。
Eur Radiol. 2023 Sep;33(9):6534-6544. doi: 10.1007/s00330-023-09620-1. Epub 2023 Apr 10.
2
Value of CEUS combined with feeding artery ablation in the microwave ablation of large solid benign thyroid nodules.超声造影联合供血动脉消融在大型实性良性甲状腺结节微波消融中的价值
Eur Radiol. 2023 Apr;33(4):2407-2414. doi: 10.1007/s00330-022-09313-1. Epub 2022 Dec 6.
3
Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study.
超声造影评估射频消融治疗良性甲状腺结节后坏死消融体积的可靠性和可重复性：一项回顾性研究。
Int J Hyperthermia. 2022;39(1):40-47. doi: 10.1080/02656736.2021.1991009.
4
Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves' disease.单次高强度聚焦超声（HIFU）治疗持续性或复发性格雷夫斯病的两年结果。
Eur Radiol. 2019 Dec;29(12):6690-6698. doi: 10.1007/s00330-019-06303-8. Epub 2019 Jun 17.
5
Single-Session High-Intensity Focused Ultrasound Treatment for Persistent or Relapsed Graves Disease: Preliminary Experience in a Prospective Study.单次高强度聚焦超声治疗持续性或复发性格雷夫斯病：一项前瞻性研究的初步经验。
Radiology. 2017 Dec;285(3):1011-1022. doi: 10.1148/radiol.2017162776. Epub 2017 Jul 20.
6
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.2016年美国甲状腺协会甲状腺功能亢进症及其他甲状腺毒症病因的诊断和管理指南。
Thyroid. 2016 Oct;26(10):1343-1421. doi: 10.1089/thy.2016.0229.
7
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.近年来，意大利新诊断的格雷夫斯病的表型比过去更为温和：一项大型观察性纵向研究的结果
J Endocrinol Invest. 2016 Dec;39(12):1445-1451. doi: 10.1007/s40618-016-0516-7. Epub 2016 Jul 27.
8
Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.预测格雷夫斯甲亢患者开始抗甲状腺药物治疗前的复发风险。
J Clin Endocrinol Metab. 2016 Apr;101(4):1381-9. doi: 10.1210/jc.2015-3644. Epub 2016 Feb 10.